搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
生物技术与医疗研究
/
rxrx
/
财务摘要
Recursion Pharmaceuticals Inc
RXRX
添加自选
3.200
USD
+0.040
+1.27%
收盘 09-11 16:00(美东)
1.70B
总市值
亏损
市盈率 TTM
盘后交易 18:44 (美东)
3.200
USD
+0.010
+0.31%
Recursion Pharmaceuticals Inc
3.200
+0.040
+1.27%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
RXRX 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Recursion Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
1.70B
股息TTM
0.00
市盈率 TTM
-2.75
每股收益TTM
-1.16
营业收入
74.68M
净利润
-463.66M
净资产收益率
-57.16%
总资产收益率
-42.33%
Recursion Pharmaceuticals Inc 财报日历
最新发布
8月 5, 2026
每股收益 / 预测值
-0.25
/-0.23
营业收入 / 预测值
7.67M
/11.95M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
40.26%
-0.25
55.84%
-0.22
61.03%
-0.21
-7.03%
-0.36
-2.27%
-0.41
-29.86%
-0.50
-31.70%
-0.53
22.46%
-0.34
-3.17%
-0.40
-13.56%
-0.39
-30.45%
-0.40
--
-0.44
--
-0.39
--
-0.34
--
-0.31
--
-1.06
--
--
--
--
--
--
--
--
营业收入
-60.10%
7.67M
-56.11%
6.47M
681.74%
35.54M
-80.16%
5.17M
33.34%
19.22M
6.89%
14.74M
-58.26%
4.55M
147.62%
26.08M
30.86%
14.42M
13.68%
13.79M
-20.36%
10.89M
-19.96%
10.53M
43.56%
11.02M
127.53%
12.13M
439.91%
13.68M
419.34%
13.16M
201.06%
7.67M
108.16%
5.33M
--
2.53M
--
2.53M
净利润
23.79%
-131.00M
41.97%
-117.50M
39.56%
-108.12M
-69.29%
-162.25M
-76.23%
-171.90M
-121.60%
-202.49M
-92.38%
-178.91M
-3.04%
-95.84M
-27.13%
-97.54M
-39.87%
-91.37M
-61.75%
-93.00M
-53.89%
-93.02M
-17.03%
-76.73M
-16.70%
-65.33M
11.46%
-57.49M
-27.45%
-60.45M
-51.06%
-65.56M
-82.24%
-55.98M
--
-64.93M
--
-47.43M
利润率
-91.01%
-1708.02%
-32.21%
-1815.57%
92.27%
-304.24%
-753.23%
-3135.32%
-32.17%
-894.23%
-107.31%
-1373.26%
-360.89%
-3935.46%
58.39%
-367.46%
2.85%
-676.56%
-23.04%
-662.41%
-103.12%
-853.88%
--
-883.10%
--
-696.43%
--
-538.38%
--
-420.39%
--
-695.47%
--
--
--
--
--
--
--
--
毛利率
-920.94%
-49.82%
-93.54%
-92.99%
132.98%
59.83%
-442.36%
-183.81%
-113.48%
-4.88%
-352.17%
-48.04%
-2056.44%
-181.43%
1743.89%
53.69%
143.88%
36.19%
836.22%
19.05%
-55.28%
9.27%
--
-3.27%
--
14.84%
--
-2.59%
--
20.74%
--
-43.06%
--
--
--
--
--
--
--
--
资产负债率
-33.56%
1.17%
-35.98%
1.23%
-33.21%
1.27%
-62.38%
1.49%
-55.94%
1.76%
850.16%
1.92%
984.56%
1.89%
1269.88%
3.95%
1356.24%
4.00%
-31.18%
0.20%
93.55%
0.17%
--
0.29%
--
0.27%
--
0.29%
--
0.09%
--
0.11%
--
--
--
--
--
--
--
--
利润表
营业收入
-60.10%
7.67M
-56.11%
6.47M
681.74%
35.54M
-80.16%
5.17M
33.34%
19.22M
6.89%
14.74M
-58.26%
4.55M
147.62%
26.08M
30.86%
14.42M
13.68%
13.79M
-20.36%
10.89M
-19.96%
10.53M
43.56%
11.02M
127.53%
12.13M
439.91%
13.68M
419.34%
13.16M
201.06%
7.67M
108.16%
5.33M
--
2.53M
--
2.53M
营业利润
23.41%
-134.97M
32.85%
-128.50M
41.05%
-108.33M
-75.08%
-172.20M
-75.28%
-176.23M
-98.64%
-191.37M
-85.76%
-183.77M
1.20%
-98.35M
-23.04%
-100.54M
-40.30%
-96.34M
-62.23%
-98.93M
-59.09%
-99.55M
-28.91%
-81.72M
-22.66%
-68.67M
6.12%
-60.98M
-34.85%
-62.57M
-54.88%
-63.39M
-83.64%
-55.98M
--
-64.96M
--
-46.40M
净利润
23.79%
-131.00M
41.97%
-117.50M
39.56%
-108.12M
-69.29%
-162.25M
-76.23%
-171.90M
-121.60%
-202.49M
-92.38%
-178.91M
-3.04%
-95.84M
-27.13%
-97.54M
-39.87%
-91.37M
-61.75%
-93.00M
-53.89%
-93.02M
-17.03%
-76.73M
-16.70%
-65.33M
11.46%
-57.49M
-27.45%
-60.45M
-51.06%
-65.56M
-82.24%
-55.98M
--
-64.93M
--
-47.43M
资产负债表
流动资产
2.78%
603.46M
21.47%
709.56M
13.80%
812.85M
50.60%
714.11M
12.40%
587.16M
70.00%
584.14M
63.02%
714.27M
15.50%
474.17M
21.20%
522.38M
-30.18%
343.62M
-23.11%
438.14M
-14.76%
410.52M
-21.06%
431.02M
-20.56%
492.13M
6.56%
569.81M
-19.85%
481.62M
-15.69%
546.00M
179.26%
619.46M
--
534.72M
--
600.87M
流动负债总额
-26.91%
119.89M
-8.65%
129.70M
-21.21%
147.71M
42.44%
155.10M
90.54%
164.03M
92.07%
141.98M
101.21%
187.47M
15.69%
108.89M
-24.46%
86.08M
-19.78%
73.92M
-7.08%
93.17M
13.35%
94.12M
17.91%
113.96M
7.52%
92.15M
114.89%
100.27M
93.36%
83.04M
227.19%
96.65M
219.15%
85.70M
--
46.66M
--
42.94M
总资产
-6.89%
1.21B
2.63%
1.34B
1.76%
1.47B
92.64%
1.40B
67.86%
1.30B
133.98%
1.31B
121.60%
1.45B
15.17%
726.50M
16.37%
775.86M
-11.08%
557.85M
-6.79%
653.70M
3.15%
630.83M
-0.86%
666.70M
-14.56%
627.37M
14.90%
701.29M
-7.15%
611.53M
-3.73%
672.51M
170.03%
734.32M
--
610.35M
--
658.61M
总负债
-22.32%
297.67M
-15.23%
314.75M
-17.05%
343.26M
74.60%
352.58M
100.20%
383.21M
136.95%
371.29M
117.50%
413.82M
4.71%
201.94M
-3.20%
191.41M
-20.54%
156.70M
-11.70%
190.26M
-13.71%
192.86M
-15.83%
197.74M
-18.09%
197.19M
219.67%
215.48M
275.16%
223.50M
320.46%
234.94M
324.89%
240.75M
--
67.41M
--
59.57M
总权益
-0.45%
915.00M
9.72%
1.02B
9.29%
1.13B
99.59%
1.05B
57.27%
919.15M
132.82%
933.95M
123.28%
1.03B
19.77%
524.56M
24.63%
584.45M
-6.75%
401.15M
-4.60%
463.44M
12.87%
437.97M
7.17%
468.96M
-12.84%
430.18M
-10.52%
485.81M
-35.22%
388.03M
-31.92%
437.58M
129.27%
493.57M
--
542.94M
--
599.03M
现金流量表
经营净额
-38.64%
-105.95M
38.54%
-81.10M
60.09%
-46.07M
-98.16%
-117.36M
7.06%
-76.42M
-28.99%
-131.96M
-55.82%
-115.43M
18.78%
-59.23M
-21.87%
-82.22M
-39.53%
-102.30M
-65.54%
-74.08M
-33.70%
-72.92M
-9.48%
-67.47M
-194.74%
-73.32M
26.83%
-44.75M
-65.04%
-54.54M
-83.11%
-61.62M
351.63%
77.39M
--
-61.16M
--
-33.05M
投资净额
66.27%
-1.96M
95.35%
-338.00K
-100.45%
-1.24M
44.13%
-2.55M
-38.88%
-5.81M
-9.27%
-7.27M
11171.38%
275.46M
-1214.70%
-4.56M
-103.70%
-4.18M
-24.59%
-6.65M
68.82%
-2.49M
-100.65%
-347.00K
-141.56%
-2.05M
-103.73%
-5.34M
84.73%
-7.98M
127.33%
52.98M
179.52%
4.94M
838.07%
143.30M
--
-52.24M
--
-193.87M
融资净额
-101.30%
-1.27M
-108.56%
-3.47M
1140.77%
132.01M
1426.79%
251.34M
-62.88%
97.66M
191.62%
40.53M
-86.81%
10.64M
-69.38%
16.46M
6848.03%
263.12M
623.05%
13.90M
-45.23%
80.66M
2200.60%
53.77M
41.94%
3.79M
-7.77%
1.92M
3779.24%
147.26M
121.06%
2.34M
-99.42%
2.67M
-2.34%
2.08M
--
3.80M
--
-11.10M
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Recursion Pharmaceuticals Inc的总收入是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,总收入达到了74.68M(同比变化58.84M)。
Recursion Pharmaceuticals Inc的流动资产是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,流动资产为812.85M(同比变化13.80)。
Recursion Pharmaceuticals Inc的总资产是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的总资产为1.47B(同比变化1.76)。
Recursion Pharmaceuticals Inc的总负债是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的总负债为343.26M(同比变化-17.05)。
Recursion Pharmaceuticals Inc的总权益是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的总权益为1.13B(同比变化9.29)。
Recursion Pharmaceuticals Inc的净营业收入是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的净营业收入为-648.13M(同比变化-35.31)。
Recursion Pharmaceuticals Inc的净投资是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的净投资为-16.87M(同比变化-106.49)。
Recursion Pharmaceuticals Inc的净融资是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,Recursion Pharmaceuticals Inc的净融资为521.53M(同比变化71.49)。
Recursion Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-1.44(同比变化14.78)。
Recursion Pharmaceuticals Inc的净利润是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,净利润为-644.76M(同比变化-39.06)。
Recursion Pharmaceuticals Inc的净利润率是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,净利润率为-863.35(同比变化-9.56)。
Recursion Pharmaceuticals Inc的毛利率是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,毛利率为4.99(同比变化-78.40)。
Recursion Pharmaceuticals Inc的债务与资产比率是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,债务与资产比率为1.27(同比变化-33.21)。
Recursion Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-59.54(同比变化3.80)。
Recursion Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-44.12(同比变化-0.02)。
Recursion Pharmaceuticals Inc的营业利润是多少?
根据Recursion Pharmaceuticals Inc的FY2025财报,营业利润为-648.13M(同比变化-35.31)。